These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing, reported early||2005-005358-27||Efficacy of Rituximab (Mabthera) in active ankylosing spondylitis: a clinical and magnetic resonance imaging study||not-yet-due|
|Ongoing, reported early||2007-001810-18||Treatment of gastrostomy related granuloma using hydrocortisone or tea tree oil: A randomized controlled trial.||not-yet-due|
|Ongoing, reported early||2008-000511-16||Management of Asthma in School age Children On Therapy||not-yet-due|
|Reported results Terminated||2012-000801-64||A Phase IV Acceptability and Feasibility Trial of the Effects of Medication on Memory in Idiopathic Nondementing Parkinson’s Disease.||2015-03-04||due-trials|
|Reported results Terminated||2014-000335-17||The Effect of Rotigotine on Memory in Idiopathic Parkinson's Disease without Cognitive Impairment||2015-06-12||due-trials|
|Ongoing||2015-000273-13||Mobilisation of endothelial progenitor cells by statin therapy in patients with coronary disease: a proof of concept pilot study.||not-yet-due|
|Ongoing||2015-005752-10||The relationship between computerised tomographic coronary angiography (CTCA) calcium scoring and endothelial progenitor cell (EPC) count. Study A and B.||not-yet-due|
|Ongoing||2016-000355-27||The effect on Endothelial progenitor cells (EPCs) by statin loading in “all comers” with an Acute Coronary Syndrome (ACS).||not-yet-due|
|Ongoing||2016-003406-14||The Metoclopramoide and selective oral decontamination for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a 2x2 double-blind, randomized controlled trial of metoclopramide and selective oral decontam...||not-yet-due|